finerenone
finerenone: 4 clinical trials tracked.
finerenone evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about finerenone, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 2 study sponsors
Clinical Trials (4)
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Investigate the Efficacy, Safety, and PK/ PD of Finerenone, in Addition to Standard-of-care, in Pediatric Patients, 6 Months to < 18 Years of Age With Heart Failure (HF) and Left Ventricular Systolic Dysfunction (LVSD)
Primary endpoint: Change in NT-proBNP levels
Optimization of Albuminuria-Lowering Therapies for Individual Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Pilot Remote Clinical Trial.
Primary endpoint: Questionnaire results
Randomized Trial to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Heart Failure Patients With Left Ventricular Ejection Fraction Greater Than or Equal to 40% Hospitalized Due to an Episode of Acute Decompensated Heart Failure (REDEFINE-HF)
Primary endpoint: Composite of total HF events and cardiovascular (CV) death.
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Phase 3 Study to Investigate the Efficacy and Safety of FInerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Patients With Non-Diabetic Chronic Kidney Disease
Primary endpoint: Mean rate of change as measured by the total slope of eGFR from baseline to Month-32.